bluuebunny/crossref_metadata_2025_split huggingface dataset:
New oscillation results for second-order neutral delay dynamic equations
Authors: Zhang Chenghui , Agarwal Ravi P , Bohner Martin , Li Tongxing 
Published: February 2013

Abstract
This paper is concerned with oscillatory behavior of a certain class of second-order neutral delay dynamic equations

(
r
(
t
)

[
x
(
t
)
+
p
(
t
)
x

(
τ
(
t
)
)

]

Δ

)

Δ

+
q
(
t
)
x

(
δ
(
t
)
)

=
0
,

on a time scale

T

with

sup
T
=
∞

, where

0
≤
p
(
t
)
≤

p
0

<
∞

. Some new results are presented that not only complement and improve those related results in the literature, but also improve some known results for a second-order delay dynamic equation without a neutral term. Further, the main results improve some related results for second-order neutral differential equations.

MSC:34K11, 34N05, 39A10.
Potency of a vaccine prepared from A/swine/Hokkaido/2/1981 (H1N1) against A/Narita/1/2009 (H1N1) pandemic influenza virus strain
Authors: Okamatsu Masatoshi , Sakoda Yoshihiro , Hiono Takahiro , Yamamoto Naoki , Kida Hiroshi 
Published: February 2013

AbstractBackgroundThe pandemic 2009 (H1N1) influenza virus has spread throughout the world and is now causing seasonal influenza. To prepare for the emergence of pandemic influenza, we have established a library of virus strains isolated from birds, pigs, and humans in global surveillance studies.MethodsInactivated whole virus particle (WV) and ether-split (ES) vaccines were prepared from an influenza virus strain, A/swine/Hokkaido/2/1981 (H1N1), from the library and from A/Narita/1/2009 (H1N1) pandemic strain. Each of the vaccines was injected subcutaneously into mice and their potencies were evaluated by challenge with A/Narita/1/2009 (H1N1) virus strain in mice.ResultsA/swine/Hokkaido/2/81 (H1N1), which was isolated from the lung of a diseased piglet, was selected on the basis of their antigenicity and growth capacity in embryonated chicken eggs. Two injections of the WV vaccine induced an immune response in mice, decreasing the impact of disease caused by the challenge with A/Narita/1/2009 (H1N1), as did the vaccine prepared from the homologous strain.ConclusionThe WV vaccine prepared from an influenza virus in the library is useful as an emergency vaccine in the early phase of pandemic influenza.
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Authors: Staropoli Nicoletta , Ciliberto Domenico , Botta Cirino , Fiorillo Lucia , Gualtieri Simona , Salvino Angela , Tassone Pierfrancesco , Tagliaferri Pierosandro 
Published: February 2013

Abstract

Background
Ovarian cancer (OC) is the sixth most common cancer in women. Currently, carboplatin/paclitaxel ± bevacizumab is the cornerstone of front-line treatment. Conversely, the therapeutic options for recurrent or progressive disease are not well defined. For platinum-sensitive patients the best therapeutic approach is still a re-challenge with a platinum-based regimen. Pegylated liposomal doxorubicin (PLD), is considered one of the most active therapeutic options for recurrent or progressive OC. In this retrospective mono-institutional analysis, we evaluated the impact of PLD on the outcome of OC patients.

Patients and methods
We performed the retrospective study on a cohort of 108 patients with histologically confirmed serous papillary OC, followed at our Institution between 2001 and 2011. 80 patients were in stage III/IV and 55 of them received a second-line treatment. Thirty patients were treated with PLD. Both groups (PLD-treated versus PLD-untreated) underwent a median of 3 treatment lines and were prognostically balanced. The median follow-up was 60 months. Survival endpoints, toxicity and correlations between patients’ baseline characteristics and treatment efficacy were evaluated.

Results
Patients who had undergone PLD treatment (PLD group) showed a median overall survival (OS) of 45 months as compared to 65 months of patients not treated with PLD (PLD-free group) (HR 2.50 [0.95-6.67; p = 0.06]). Moreover, the median progression-free survival was 6 months in the PLD group versus 10 months in the PLD-free group (HR 1.75 [0.94-3.34; p = 0.07]). The overall objective response rate in II line treatment was 43% (13% in PLD group versus 57% in PLD-free group). Furthermore, we investigated survival endpoints in platinum-refractory patients who received PLD at least once during the course of disease. No OS advantage was achieved by PLD administration when compared to other therapeutic options (30 versus 32 months; HR 1.16 [0.31-4.34; p = 0.81]). No difference in term of toxicity was observed among different groups.

Conclusions
No evidence of superiority if PLD was compared to alternative agents was found in this analysis, particularly in the platinum-refractory setting. Our findings indicate a modest therapeutic activity of PLD in OC. Analysis of cost/benefit of PLD in OC is eagerly awaited.
The regulation of cellular metabolism by tumor suppressor p53
Authors: Liang Yingjian , Liu Juan , Feng Zhaohui 
Published: February 2013

AbstractAs a hallmark of tumor cells, metabolic alterations play a critical role in tumor development and could be targeted for tumor therapy. Tumor suppressor p53 plays a central role in tumor prevention. As a transcription factor, p53 mainly exerts its function in tumor suppression through its transcriptional regulation of its target genes to initiate various cellular responses. Cell cycle arrest, apoptosis and senescence are most well-understood functions of p53, and are traditionally accepted as the major mechanisms for p53 in tumor suppression. Recent studies have revealed a novel function of p53 in regulation of cellular metabolism. p53 regulates mitochondrial oxidative phosphorylation, glycolysis, glutamine metabolism, lipid metabolism, and antioxidant defense. Through the regulation of these metabolic processes, p53 maintains the homeostasis of cellular metabolism and redox balance in cells, which contributes significantly to the role of p53 as a tumor suppressor. Further understanding of the role and molecular mechanism of p53 in cellular metabolism could lead to the identification of novel targets and development of novel strategies for tumor therapy.
Glucocorticoid-Induced Suppression of β-Cell Proliferation Is Mediated by Mig6
Authors: Colvin E. Scott , Ma Hong-Yun , Chen Yi-Chun , Hernandez Angelina M. , Fueger Patrick T. 
Published: February 2013

AbstractGlucocorticoids can cause steroid-induced diabetes or accelerate the progression to diabetes by creating systemic insulin resistance and decreasing functional β-cell mass, which is influenced by changes in β-cell function, growth, and death. The synthetic glucocorticoid agonist dexamethasone (Dex) is deleterious to functional β-cell mass by decreasing β-cell function, survival, and proliferation. However, the mechanism by which Dex decreases β-cell proliferation is unknown. Interestingly, Dex induces the transcription of an antiproliferative factor and negative regulator of epidermal growth factor receptor signaling, Mig6 (also known as gene 33, RALT, and Errfi1). We, therefore, hypothesized that Dex impairs β-cell proliferation by increasing the expression of Mig6 and thereby decreasing downstream signaling of epidermal growth factor receptor. We found that Dex induced Mig6 and decreased [3H]thymidine incorporation, an index of cellular replication, in mouse, rat, and human islets. Using adenovirally delivered small interfering RNA targeted to Mig6 in rat islets, we were able to limit the induction of Mig6 upon exposure to Dex, compared with islets treated with a control virus, and completely rescued the Dex-mediated impairment in replication. We demonstrated that both Dex and overexpression of Mig6 attenuated the phosphorylation of ERK1/2 and blocked the G1/S transition of the cell cycle. In conclusion, Mig6 functions as a molecular brake for β-cell proliferation during glucocorticoid treatment in β-cells, and thus, Mig6 may be a novel target for preventing glucocorticoid-induced impairments in functional β-cell mass.
New Insights into the Anti-inflammatory Mechanisms of Glucocorticoids: An Emerging Role for Glucocorticoid-Receptor-Mediated Transactivation
Authors: Vandevyver Sofie , Dejager Lien , Tuckermann Jan , Libert Claude 
Published: February 2013

AbstractGlucocorticoids are anti-inflammatory drugs that are widely used for the treatment of numerous (autoimmune) inflammatory diseases. They exert their actions by binding to the glucocorticoid receptor (GR), a member of the nuclear receptor family of transcription factors. Upon ligand binding, the GR translocates to the nucleus, where it acts either as a homodimeric transcription factor that binds glucocorticoid response elements (GREs) in promoter regions of glucocorticoid (GC)-inducible genes, or as a monomeric protein that cooperates with other transcription factors to affect transcription. For decades, it has generally been believed that the undesirable side effects of GC therapy are induced by dimer-mediated transactivation, whereas its beneficial anti-inflammatory effects are mainly due to the monomer-mediated transrepressive actions of GR. Therefore, current research is focused on the development of dissociated compounds that exert only the GR monomer-dependent actions. However, many recent reports undermine this dogma by clearly showing that GR dimer-dependent transactivation is essential in the anti-inflammatory activities of GR. Many of these studies used GRdim/dim mutant mice, which show reduced GR dimerization and hence cannot control inflammation in several disease models. Here, we review the importance of GR dimers in the anti-inflammatory actions of GCs/GR, and hence we question the central dogma. We summarize the contribution of various GR dimer-inducible anti-inflammatory genes and question the use of selective GR agonists as therapeutic agents.
Antipsychotic Prescribing Patterns, and the Factors and Outcomes Associated with Their Use, among Patients Requiring Prolonged Mechanical Ventilation in the Long-Term Acute Care Hospital Setting
Authors: Al-Qadheeb Nada S , O'Connor Heidi H , White Alexander C , Neidhardt Aura , Albizati Mark , Joseph Bernard , Roberts Russel J , Ruthazer Robin R , Devlin John W 
Published: February 2013

BACKGROUND: Administration of scheduled antipsychotic therapy to mechanically ventilated patients to prevent or treat delirium is common, despite the lack of evidence to support its use. Among long-term acute care hospital (LTACH) patients requiring prolonged mechanical ventilation (PMV), the frequency of scheduled antipsychotic therapy use, and the factors and outcomes associated with it, have not been described. OBJECTIVE: To identify scheduled antipsychotic therapy prescribing practices, and the factors and outcomes associated with the use of antipsychotics, among LTACH patients requiring PMV. METHODS: Consecutive patients without major psychiatric disorders or dementia who were admitted to an LTACH for PMV over 1 year were categorized as those receiving scheduled antipsychotic therapy (≥24 hours of use) and those not receiving scheduled antipsychotic therapy. Presence of delirium, use of psychiatric evaluation, nonscheduled antipsychotic therapy, and scheduled antipsychotic therapy—related adverse effects were extracted and compared between the 2 groups and when significant (p ≤ 0.05), were entered into a regression analysis using generalized estimating equation techniques. RESULTS: Among 80 patients included, 39% (31) received scheduled antipsychotic therapy and 61% (49) did not. Baseline characteristics, including age, sex, illness severity, and medical history, were similar between the 2 groups. Scheduled antipsychotic therapy was administered on 52% of LTACH days for a median (interquartile range [IQR]) of 25 (6–38) days and, in the antipsychotic group, was initiated at an outside hospital (45%) or on day 2 (1–6; median [IQR]) of the LTACH stay (55%). Quetiapine was the most frequently administered scheduled antipsychotic (77%; median dose 50 [37–72] mg/day). Use of scheduled antipsychotic therapy was associated with a greater incidence of psychiatric evaluation (OR 5.7; p = 0.01), delirium (OR 2.4; p = 0.05), as-needed antipsychotic use (OR 4.1; p = 0.005) and 1:1 sitter use (OR 7.3; p = 0.001), but not benzodiazepine use (p = 0.19). CONCLUSIONS: Among LTACH patients requiring PMV, scheduled antipsychotic therapy is used frequently and is associated with a greater incidence of psychiatric evaluation, delirium, as-needed psychotic use, and sitter use. Although scheduled antipsychotic therapy—related adverse effects are uncommon, these effects are infrequently monitored.
Role of Phosphodiesterase Type 5 Inhibitors for Lower Urinary Tract Symptoms
Authors: Miller Mindi S 
Published: February 2013

OBJECTIVE: To determine the efficacy of phosphodiesterase inhibitors for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). DATA SOURCES: MEDLINE and PubMed were searched from January 1, 2000, to October 31, 2012, using the MeSH terms phosphodiesterase inhibitor, lower urinary tract symptoms, benign prostatic hyperplasia, sildenafil, vardenafil, and tadalafil. Additional articles were obtained from references identified in the original search. STUDY SELECTION AND DATA EXTRACTION: English-language randomized controlled trials and review articles were evaluated. DATA SYNTHESIS: Men with BPH commonly experience lower urinary tract symptoms (LUTS) such as urgency, frequency, nocturia, and dribbling. α-Adrenergic antagonists have been the mainstay of medical treatment of LUTS but are associated with adverse effects such as orthostatic hypotension, dizziness, and sexual dysfunction. The 5-α reductase inhibitors are associated with sexual dysfunction, and treatment effects may be delayed for 6–12 months. Phosphodiesterase type 5 (PDE-5) inhibitors are effective for the treatment of erectile dysfunction (ED), and large-scale epidemiologic studies suggest a strong link between LUTS and ED. The available PDE-5 inhibitors (sildenafil, tadalafil, and vardenafil) have shown efficacy in the treatment of LUTS in several randomized controlled trials in men with and without concomitant ED. CONCLUSIONS: PDE-5 inhibitors consistently reduce LUTS associated with BPH. These medications may offer advantages over conventional therapies such as rapid onset of action, fewer adverse effects, and enhanced sexual function. Quality of life improvements have also been realized in men with BPH who receive PDE-5 inhibitors.
Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study
Authors: Smans Lisanne C C J , Souverein Patrick C , Leufkens Hubert G M , Hoepelman Andy I M , Zelissen Pierre M J 
Published: February 2013

BackgroundPrevious studies have suggested that infections are an important cause of death in patients with Addison's disease, but epidemiological studies on the frequency of infections in this population are lacking.ObjectiveTo assess and compare the incidence risk of infections in patients with primary adrenal insufficiency with controls.Design and settingWe conducted a cohort study, using data from the Dutch PHARMO record linkage system, that links patients' demographics and medication histories to hospital admissions.PatientsFrom a cohort of oral glucocorticoid users, 390 patients with primary adrenal insufficiency were identified by assessing concurrent use of glucocorticoids and mineralocorticoids using pharmacy dispensing records. A reference cohort (n=1933) with the same age and sex distribution was sampled from patients not using glucocorticoids.Outcome measureIncidence rates and incidence rate ratios (IRR) were calculated of infections, defined by use of antimicrobial agents, as well as hospital admissions for infection.ResultsThe incidence of infectious episodes, defined by usage of antimicrobial agents, among patients with primary adrenal insufficiency (incidence rate 59.2/100 person-years) was 1.5 times higher compared with controls, yielding a crude IRR of 1.61 (95% CI 1.51–1.72). The IRR decreased slightly to 1.58 (95% CI 1.47–1.70) after adjustment for co-medication and co-morbidity also associated with infection risk. Also with respect to hospital admissions for infection, the incidence rates observed for patients with primary adrenal insufficiency was higher compared with controls (3.8/100 vs 0.8/100 person-years): crude IRR 5.02 (3.66–6.87) and adjusted IRR 4.34 (95% CI 3.04–6.22).ConclusionPatients with primary adrenal insufficiency had an increased use of antimicrobial agents and hospital admissions related to infection.
Effect of Substrate Elasticity onIn VitroAging of Human Mesenchymal Stem Cells
Authors: LeBlon Courtney E. , Fodor Caitlin R. , Zhang Tony , Zhang Xiaohui , Jedlicka Sabrina S. 
Published: February 2013

ABSTRACTHuman mesenchymal stem cells (hMSCs) were routinely cultured on tissue-culture polystyrene (TCPS) to investigate thein vitroaging and cell stiffening. hMSCs were also cultured on thermoplastic polyurethane (TPU), which is a biocompatible polymer with an elastic modulus of approximately 12.9MPa, to investigate the impact of substrate elastic modulus on cell stiffening and differentiation potential. Cells were passaged over several generations on each material. At each passage, cells were subjected to osteogenic and myogenic differentiation. Local cell elastic modulus was measured at every passage using atomic force microscopy (AFM) indentation. Gene and protein expression was examined using qRT-PCR and immunofluorescent staining, respectively, for osteogenic and myogenic markers. Results show that the success of myogenic differentiation is highly reliant on the elastic modulus of the undifferentiated cells. The success of osteogenic differentiations is most likely somewhat dependent on the cell elastic modulus, as differentiations were more successful in earlier passages, when cells were softer.
The Role of Disorder and the Elastic Robustness of Bulk Metallic Glasses
Authors: Derlet P. M. , Maaß R. 
Published: February 2013

ABSTRACTDespite significant atomic-scale heterogeneity, bulk metallic glasses well below their glass transition temperature exhibit a surprisingly robust elastic regime and a sharp elastic-to-plastic transition with a yield stress that depends approximately linearly on temperature. The present work attempts to understand these features within the framework of thermally activated plasticity. The presented statistical thermal activation model, in which the number of available structural transformations scales exponentially with system size, results in two distinct temperature regimes of deformation. At temperatures close to the glass transition temperature thermally activated Newtonian plastic flow emerges, whilst at lower temperatures the deformation properties fundamentally change due to the eventual kinetic freezing of the available structural transformations. In this regime, a linear temperature dependence emerges for the stress which characterises the elastic to plastic transition. For both regimes the transition to macroscopic plastic flow corresponds to a transition from a barrier energy dominated to a barrier entropy dominated statistics. The work concludes by discussing the possible influence that kinetic freezing might have on the low temperature heterogeneous and high temperature homogeneous plasticity of bulk metallic glasses.
Transmission Fourier Transform Infra-red Spectroscopy Investigation of Structure Property Relationships in Low-k SiOxCy:H Dielectric Thin Films
Authors: King Sean W. , Mays Ebony , Ege Canay , Hellgren Niklas , Xu Jessica , Li Han , Boyanov Boyan 
Published: February 2013

ABSTRACTIn order to understand the structure property relationships for inorganic low dielectric constant (i.e. low-k) materials, transmission Fourier Transform-Infrared (FTIR) spectroscopy has been utilized to study the local bonding structure in various plasma enhanced chemically vapor deposited low-k materials in the SiOxCy:H phase diagram. The FTIR measurements were combined with additional mechanical, electrical, and optical property measurements to elucidate the structure property relationships for these materials. The combined measurements show that increased incorporation of terminal methyl bonding results in a decrease in network bonding that manifests itself in a reduction in mass density, dielectric constant, refractive index, Young’s modulus and many other important material properties.
Synthesis and Characterization of Cu-doped ZnO Film in Nanowire like Morphology Using Low Temperature Self-Catalytic Vapor-Liquid-Solid (VLS) Method
Authors: Thankalekshmi Ratheesh R. , Dixit Samwad , Bae In-Tae , VanHart Daniel , Rastogi A.C. 
Published: February 2013

ABSTRACTCu-doped ZnO film in nanowire structure is synthesized by a closed space flux sublimation and periodic oxidation method at ∼300°C over Si substrate. Oxidative process controlled selfcatalytic VLS mechanism is proposed for the film growth. X-ray diffraction pattern establishes that Cu-doped ZnO nanowires retain the crystallite structure of the wurtzite ZnO. TEM studies indicate single crystal character of the Cu-doped ZnO nanowires. Optical absorption analysis of Cu-doped ZnO nanowires defines two direct energy band gaps. The low energy band gap at 3.2eV is intrinsic to the Cu-doped ZnO material. The higher energy band gap at 3.5eV is attributed to the nanosize, mediated by strong forward scattering of light from the nanowires. Sharp photoluminescence in Cu-doped ZnO corresponding to near bandgap free exciton emission is observed and a redshift of ∼0.07 eV is consistent with the effect of Cu-doping. The visible emission band in both ZnO and Cu-doped ZnO shows a broad green emission band with Cu-substitution shifting the maximum visible luminescence towards the higher energy side.
Development of the Synthetic Rock Technique for the Immobilization of Iodine: Kinetics of the Alumina Matrix Dissolution under High Alkaline Conditions
Authors: Miyakawa Hideaki , Sakuragi Tomofumi , Owada Hitoshi , Kato Osamu , Masuda Kaoru 
Published: February 2013

ABSTRACTIodine filters expended after nuclear fuel reprocessing contain radioactive iodine (I-129), almost all of which exists as silver iodide (AgI). The synthetic rock technique is a solidification treatment technique using hot isostatic press (HIP), in which the alumina adsorbent base material is synthesized to form a dense solidified material (synthetic rock), and I-129 is physically confined in the form of AgI in the alumina matrix. Thus, it is necessary to understand the matrix dissolution behavior to evaluate the iodine release behavior.Experiments involving the dissolution of the matrix were carried out under various temperatures (35–70 °C) and pH values (10–12.5) that reflect the disposal conditions. The results of the experiments showed that the dissolution rate of Al visibly increases with temperature and pH. The dissolution rate constant was calculated from the initial data assuming the dissolution of the matrix as a primary reaction. The logarithmic rate constant showed a good linear correlation with the pH and the reciprocal of temperature. The 27Al-NMR analysis of the solutions of the dissolved matrix showed that the major chemical species present in the solutions was Al(OH)4-. This indicated that the dissolution of the matrix can be described by the following equation: Al2O3 + 2OH- + 3H2O → 2Al(OH)4-. Subsequently, the empirical equation of the rate of dissolution of the matrix as a function of the temperature and pH was derived. It will be used to evaluate the iodine release behavior from the synthetic rock.